Dynavax Technologies Corporation
DVAX
$10.40
$0.100.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 41.43% | -8.58% | |||
| Total Other Revenue | 11.39% | 227.37% | |||
| Total Revenue | 40.02% | -5.37% | |||
| Cost of Revenue | -48.18% | 3.79% | |||
| Gross Profit | 120.64% | -12.43% | |||
| SG&A Expenses | -14.64% | 42.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.04% | 25.34% | |||
| Operating Income | 177.81% | -3,828.92% | |||
| Income Before Tax | 121.68% | -1,382.93% | |||
| Income Tax Expenses | 240.48% | -406.74% | |||
| Earnings from Continuing Operations | 119.48% | -1,463.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 119.48% | -1,463.11% | |||
| EBIT | 177.81% | -3,828.92% | |||
| EBITDA | 188.46% | -1,250.80% | |||
| EPS Basic | 120.39% | -1,496.73% | |||
| Normalized Basic EPS | 240.63% | -311.80% | |||
| EPS Diluted | 118.73% | -1,878.29% | |||
| Normalized Diluted EPS | 221.27% | -353.21% | |||
| Average Basic Shares Outstanding | -4.45% | -2.41% | |||
| Average Diluted Shares Outstanding | 10.80% | -18.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||